| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 09/25/2003 | US20030180296 Antibodies that immunospecifically bind to trail receptors |
| 09/25/2003 | US20030180293 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody |
| 09/25/2003 | US20030180275 Human serpin polypeptides |
| 09/25/2003 | US20030180269 Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
| 09/25/2003 | US20030180268 Cell differentiation on a three-dimensional, biocompatible support |
| 09/25/2003 | US20030180267 Genetic engineering; controlling gene expression in situ |
| 09/25/2003 | US20030180266 Methods of expressing LIM mineralization protein in non-osseous cells |
| 09/25/2003 | US20030180265 Modulating angiogenesis |
| 09/25/2003 | US20030180264 Using catheter or stent; in situ tissue transfer |
| 09/25/2003 | US20030180255 IL-17 homologous polypeptides and therapeutic uses thereof |
| 09/25/2003 | US20030180225 Walnut and ryegrass allergens |
| 09/25/2003 | DE10214095C1 Producing dedifferentiated, programmable stem cells of human monocytic origin using culture medium having M-CSF and IL-3, useful in treating cirrhosis, pancreatic insufficiency, kidney failure, cardiac infarction and stroke |
| 09/25/2003 | CA2799805A1 Optimizing glycan processing in plants |
| 09/25/2003 | CA2479679A1 Methods of inducing differentiation in ex vivo expanded stem cells |
| 09/25/2003 | CA2479510A1 Primitive and proximal hepatic stem cells |
| 09/25/2003 | CA2479246A1 Method for overexpression of zwitterionic polysaccharides |
| 09/25/2003 | CA2479153A1 Hybrid and single chain meganucleases and use thereof |
| 09/25/2003 | CA2479152A1 Methods of inducing differentiation of stem cells into a specific cell lineage |
| 09/25/2003 | CA2479118A1 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 09/25/2003 | CA2479042A1 Cartilage regeneration using chondrocyte and tgf-.beta. |
| 09/25/2003 | CA2479007A1 Cells transfected with a nucleotide sequence encoding glp-1 and secreting insulin in a glucose-dependent manner |
| 09/25/2003 | CA2478987A1 Method for generating primate trophoblasts |
| 09/25/2003 | CA2478986A1 Method of identifying genes controlling differentiation |
| 09/25/2003 | CA2478973A1 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 09/25/2003 | CA2478887A1 Methods and devices for selective disruption of fatty tissue by controlled cooling |
| 09/25/2003 | CA2478651A1 Method of inducing an enhanced immune response against hiv |
| 09/25/2003 | CA2478294A1 Gntiii (udp-n-acetylglucosamine:beta-d mannoside beta (1,4)-n-acetylglucosaminyltransferase iii) expression in plants |
| 09/25/2003 | CA2477194A1 Poison/antidote genetic systems for the selection of genetically modified eucaryote cells or organisms |
| 09/25/2003 | CA2474905A1 Alcohol dehydrogenases with high solvent and temperature stability |
| 09/25/2003 | CA2463659A1 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies |
| 09/24/2003 | EP1347055A2 Compounds for immunotherapy and diagnosis of tuberculosis |
| 09/24/2003 | EP1347047A2 Mice lacking inward-rectifying potassium channel Kir6.1 |
| 09/24/2003 | EP1347041A1 Mammalian permanent growth factor-independent cell line and method of its production |
| 09/24/2003 | EP1346725A1 Pharmaceutical composition comprising PIM-activated NKT cells, and therapeutic use thereof |
| 09/24/2003 | EP1346226A1 Screening method based on siah-numb interaction |
| 09/24/2003 | EP1346217A2 Reversible mhc multimer staining for functional purification of antigen-specific t cells |
| 09/24/2003 | EP1346065A2 Antisense modulation of src-2 expression |
| 09/24/2003 | EP1346061A2 Pregnancy-associated plasma protein-a2 (papp-a2) |
| 09/24/2003 | EP1346059A1 Photochemical internalization for delivery of molecules into the cytosol |
| 09/24/2003 | EP1346058A2 Adenoviral systems and the uses thereof |
| 09/24/2003 | EP1346056A1 Methods for the production of multimeric proteins, and related compositions |
| 09/24/2003 | EP1346055A2 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 09/24/2003 | EP1346053A2 Polynucleotides encoding human phosphatases |
| 09/24/2003 | EP1346052A2 Histone deacetylase-related gene and protein |
| 09/24/2003 | EP1346051A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 09/24/2003 | EP1346049A2 EFFICIENT EXPRESSION OF i PLASMODIUM /i APICAL MEMBRANE ANTIGEN 1 IN YEAST CELLS |
| 09/24/2003 | EP1346045A1 Human protooncogene and protein encoded therein |
| 09/24/2003 | EP1346042A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 09/24/2003 | EP1346041A2 Therapeutic agents and methods of use thereof for treating an amyloidogenic disease |
| 09/24/2003 | EP1346039A1 Human cervical cancer 2 protooncogene and protein encoded therein |
| 09/24/2003 | EP1346033A2 Novel serine protease genes related to dppiv |
| 09/24/2003 | EP1346032A2 Method for the production of carbohydrates |
| 09/24/2003 | EP1346031A2 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof |
| 09/24/2003 | EP1346029A2 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 09/24/2003 | EP1346028A2 Cell culture apparatus and methods of use |
| 09/24/2003 | EP1345969A2 Anti-cd28 antibody |
| 09/24/2003 | EP1345965A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 09/24/2003 | EP1345961A2 Antigenic ck-18 compounds for therapy and diagnosis and methods for using same |
| 09/24/2003 | EP1345959A2 Membrane scaffold proteins |
| 09/24/2003 | EP1345743A1 Electroprocessed collagen |
| 09/24/2003 | EP1345627A1 Targeted modification of intracellular compounds |
| 09/24/2003 | EP1345625A2 Methods of administering/dosing anti-rsv antibodies for prophylaxis and treatment |
| 09/24/2003 | EP1345617A2 Methods of modulating toll-related receptor (trr) signaling |
| 09/24/2003 | EP1345567A2 Calcium channel transport polynucleotides, polypeptides, and antibodies |
| 09/24/2003 | EP1345495A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 09/24/2003 | EP1345491A1 Storage solution containing photosensitizer for inactivation of biological contaminants |
| 09/24/2003 | EP1095132A4 Methods for implanting cells |
| 09/24/2003 | EP1094829B1 Methods for accelerating bone and cartilage growth and repair |
| 09/24/2003 | EP1007629B1 Sugar cane production |
| 09/24/2003 | EP0922093B1 Method for making cartilage and implants |
| 09/24/2003 | EP0918509B1 Biocompatible devices with foam scaffolds |
| 09/24/2003 | EP0845963B1 The use of autologous dermal fibroblasts for the repair of skin and soft tissue defects |
| 09/24/2003 | EP0741550B1 Multiple layer alginate coatings of biological tissue for transplantation |
| 09/24/2003 | EP0686192B1 In vitro method of enhancing fertility in the presence of inhibin/activin combinations |
| 09/24/2003 | CN1444661A Method for detecting growth hormone variations in humans, the variations and their uses |
| 09/24/2003 | CN1444652A Mammalian receptor proteins, related regents and methods |
| 09/24/2003 | CN1444650A Pseudo-type retrovirus vector containing membrane protein having hemagglutinin activity |
| 09/24/2003 | CN1444648A Method of amplifying natural killer T cells |
| 09/24/2003 | CN1444602A Human receptor proteins, related reagents and methods |
| 09/24/2003 | CN1444599A Novel compounds |
| 09/24/2003 | CN1443847A Recombinant nucleic acid of coded human osteogenic protein-1 and its application |
| 09/24/2003 | CN1443840A Culture medium using sericin as nitrogen source |
| 09/24/2003 | CN1443778A Monoclonal antibody of melanic related antigen, and its application and medicine composition |
| 09/24/2003 | CN1443576A Production method of chondric implant |
| 09/24/2003 | CN1122107C Intracellular antifreeze polypeptide and nucleic acids |
| 09/24/2003 | CN1122105C Novel method viruses, anti viral compounds and novel methods of making vaccines |
| 09/23/2003 | US6624344 Transformation of cotton plants |
| 09/23/2003 | US6624342 Genetic transcription of DNA sequences that code for polypeptides having geranylgeranyl reductase activity; propagation |
| 09/23/2003 | US6624295 Heavy chain and light chain peptides comprising complement determining regions, including single chain FV fragments, used as thrombolytic agents |
| 09/23/2003 | US6624151 Concerns the uses of said compounds as selective inhibitors of T gamma 9 delta 2 lymphocytes, their uses, for therapeutic purposes. |
| 09/23/2003 | US6624145 The subject invention concerns new classes of pesticidal toxins and the polynucleotide sequences which encoded these toxins. Also described are novel pesticidal isolates of Bacillus thuringiensis soil microbe Bacillus |
| 09/23/2003 | US6624139 Applying a hypersensitive response elicitor in a non-infectious form to plants or plant seeds under conditions effective to impart stress resistance to plants or plants grown from the plant seeds. Transgenic plants or plant seeds |
| 09/23/2003 | US6623981 Detecting antibodies which bind integrin bound modulators; obtain sample, incubate with modulators and antibodies, form complexes, screen for bound complex |
| 09/23/2003 | US6623980 Mixing polypeptides with exogeneous proteins, oligopeptides, polysaccharides or polynucleotides, then analyzing binding; medical diagnosis and therapy |
| 09/23/2003 | US6623962 Enzymatic nucleic acid treatment of diseases of conditions related to levels of epidermal growth factor receptors |
| 09/23/2003 | US6623960 Monoclonal antibodies comprising complementarity determining regions (CDRs) from light chain and heavy chain variable domain peptides used for drug screening; metabolism of xenobiotics and carcinogens |
| 09/23/2003 | US6623958 Compositions and methods for non-targeted activation of endogenous genes |
| 09/23/2003 | US6623951 HBV vectors and cells for producing the same |
| 09/23/2003 | US6623949 Endoglucanase III (EGIII) from Trichoderma reesei; substitutions; improved stability; used in treatment of textile, detergent compositions, degrading wood pulp and animal feed |
| 09/23/2003 | US6623945 System and method for microwave cell lysing of small samples |